Education
About Us
Working with TipRanks
Follow Us
B.R.A.I.N. Biotechnology Research and Information Network AG (DE:BNN)
XETRA:BNN
Total Valuation
B.R.A.I.N. Biotechnology Research and Information Network has a market cap or net worth of €50.69M. The enterprise value is €68.53M.
Market Cap€50.69M
Enterprise Value€68.53M
Share Statistics
B.R.A.I.N. Biotechnology Research and Information Network has 21,847,494 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,847,494
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
B.R.A.I.N. Biotechnology Research and Information Network’s return on equity (ROE) is -6.38 and return on invested capital (ROIC) is -15.93%.
Return on Equity (ROE)-6.38
Return on Assets (ROA)-0.18
Return on Invested Capital (ROIC)-15.93%
Return on Capital Employed (ROCE)-0.17
Revenue Per Employee167.65K
Profits Per Employee-39.67K
Employee Count296
Asset Turnover0.75
Inventory Turnover5.33
Valuation Ratios
The current PE Ratio of B.R.A.I.N. Biotechnology Research and Information Network is ―. B.R.A.I.N. Biotechnology Research and Information Network’s PEG ratio is -0.69.
PE Ratio―
PS Ratio0.96
PB Ratio25.87
Price to Fair Value25.87
Price to FCF-4.42
Price to Operating Cash Flow-4.58
PEG Ratio-0.69
Income Statement
In the last 12 months, B.R.A.I.N. Biotechnology Research and Information Network had revenue of 49.62M and earned -11.74M in profits. Earnings per share was -0.54.
Revenue49.62M
Gross Profit2.01M
Operating Income-8.51M
Pretax Income-12.02M
Net Income-11.74M
EBITDA-4.17M
Earnings Per Share (EPS)-0.54
Cash Flow
In the last 12 months, operating cash flow was -11.07M and capital expenditures -1.03M, giving a free cash flow of -12.11M billion.
Operating Cash Flow-11.07M
Free Cash Flow-12.11M
Free Cash Flow per Share-0.55
Dividends & Yields
B.R.A.I.N. Biotechnology Research and Information Network pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.17
52-Week Price Change-22.15%
50-Day Moving Average2.74
200-Day Moving Average2.29
Relative Strength Index (RSI)35.24
Average Volume (3m)10.93K
Important Dates
B.R.A.I.N. Biotechnology Research and Information Network upcoming earnings date is Feb 25, 2026, Before Open (Confirmed).
Last Earnings DateJan 14, 2026
Next Earnings DateFeb 25, 2026
Ex-Dividend Date―
Financial Position
B.R.A.I.N. Biotechnology Research and Information Network as a current ratio of 1.42, with Debt / Equity ratio of 1305.21%
Current Ratio1.42
Quick Ratio0.91
Debt to Market Cap0.35
Net Debt to EBITDA-4.28
Interest Coverage Ratio-3.86
Taxes
In the past 12 months, B.R.A.I.N. Biotechnology Research and Information Network has paid -190.00K in taxes.
Income Tax-190.00K
Effective Tax Rate0.02
Enterprise Valuation
B.R.A.I.N. Biotechnology Research and Information Network EV to EBITDA ratio is -15.71, with an EV/FCF ratio of -6.08.
EV to Sales1.32
EV to EBITDA-15.71
EV to Free Cash Flow-6.08
EV to Operating Cash Flow-7.09
Balance Sheet
B.R.A.I.N. Biotechnology Research and Information Network has €6.32M in cash and marketable securities with €24.03M in debt, giving a net cash position of -€17.71M billion.
Cash & Marketable Securities€6.32M
Total Debt€24.03M
Net Cash-€17.71M
Net Cash Per Share-€0.81
Tangible Book Value Per Share-€0.49
Margins
Gross margin is 48.35%, with operating margin of -17.15%, and net profit margin of -23.66%.
Gross Margin48.35%
Operating Margin-17.15%
Pretax Margin-24.23%
Net Profit Margin-23.66%
EBITDA Margin-8.40%
EBIT Margin-18.73%
Analyst Forecast
The average price target for B.R.A.I.N. Biotechnology Research and Information Network is €5.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€5.00
Price Target Upside115.52% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-4.90%
EPS Growth Forecast-69.80%